Screenshots

Description

Thinksulin was developed by ACI in consultation with the NSW Diabetes Taskforce and its In-hospital Management of Diabetes Mellitus Working Group and informed by: an evidence check of best practice care components of inpatient insulin management brokered by the Sax Institute for the Agency for Clinical Innovation (2017); clinician and consumer consultations; and clinical expertise.

Thinksulin aims to enhance the capacity and/or capability of junior medical officers and nursing staff responsible for prescribing and administering of insulin to patients in hospital with diabetes, although it can be used by any clinician responsible for the care of people in hospital with diabetes.
Thinksulin is a point of care app that provides information and decision support on blood glucose level targets, hypoglycaemia management, blood glucose monitoring, basal-bolus calculations, and charting and reviewing doses.

What’s New

Version 1.6.0

Lantus insulin was discontinued from 1st July 2020. Optisulin and Semglee are available alternative forms of insulin glargine, and this has been reflected in this version.

App Privacy

The developer, Agency for Clinical Innovation, has not provided details about its privacy practices and handling of data to Apple. For more information, see the developer’s privacy policy.

No Details Provided

The developer will be required to provide privacy details when they submit their next app update.

Supports

  • Family Sharing

    Up to six family members will be able to use this app with Family Sharing enabled.

More By This Developer

You May Also Like